Similar Articles |
|
BusinessWeek July 18, 2005 Moon Ihlwan |
Stem Cell Sleuth Seoul is funding Hwang Woo Suk in a bid to turn Korea into a global research hub for stem cell research. |
BusinessWeek July 18, 2005 |
Research and "False Expectations" While Korean scientist Hwang Woo Suk is eager to see practical applications of his work, he warns that optimism needs to be qualified by reality. |
Scientific American March 2006 Sara Beardsley |
Down in Flames Can stem cell research recover from Woo Suk Hwang? |
ifeminists February 1, 2006 Wendy McElroy |
Questions to Ask Scientific Authority Stem cell research may be the most sensational and explosive scientific development of recent years. It also highlights the admonition, "Question Authority." |
Scientific American March 2006 |
Con Men in Lab Coats Five decades after it was revealed as a forgery, the Piltdown man still haunts paleoanthropology. Now, thanks to the disgraced stem cell researcher Woo Suk Hwang, cell biology has a high-profile scandal of its own to live down. |
BusinessWeek January 23, 2006 Arlene Weintraub |
A "Body Blow" To Stem Cell Research Funding for stem cell research in the U.S. wasn't so hot even before the Korean scandal broke. |
BusinessWeek January 10, 2005 Bruce Einhorn |
Asia Is Stem Cell Central Singapore isn't the only country in the region trying to profit from the U.S. restrictions. Australia, China, India, Japan, and South Korea all see stem cell research as a way to get ahead in biotech. |
The Motley Fool May 26, 2009 Brian Orelli |
A Less-Risky Stem Cell Play Life Technologies is a clear leader in stem cell reagents. |
Bio-IT World October 14, 2004 |
Stem Cells and the Ballot Box Science policy is seldom a pivotal factor in U.S. presidential elections, but this year might be an exception. |
Bio-IT World August 2005 Maureen McDonough |
U.K. Framework Offers Stem Cells a Future The United Kingdom has managed to cut through the noise surrounding stem cell research, creating a regulatory framework that fosters an environment of international collaboration and excellent R&D programs. And they try to do it all in an ethical way. |
The Motley Fool May 2, 2011 Brian Orelli |
StemCells Up for All the Right Reasons Federal funding doesn't matter for most stem cell companies. |
Reason October 2001 Ronald Bailey |
Blastocyst Brouhaha Which human cells count as people? |
Bio-IT World April 16, 2004 Kevin Davies |
A Black Eye for Bioethics Elizabeth Blackburn, an internationally renowned cell biologist, received a surprise phone call from the White House, informing her that her services on the President's Council on Bioethics would no longer be required. |
Wired January 2004 Wendy Goldman Rohm |
Seven Days of Creation The inside story of a human cloning experiment |
Bio-IT World April 2006 |
Virtual Stem Cell Laboratory Goes Live Children's Hospital in Boston's Virtual Stem Cell Laboratory web site allows online visitors to manipulate and investigate a "living" culture of embryonic stem cells. |
Scientific American July 2008 Sally Lehrman |
Dolly's Creator Moves Away from Cloning and Embryonic Stem Cells Like many stem cell pioneers, Ian Wilmut, the creator of Dolly the sheep, has jumped to an alternative approach. Is this the beginning of the end for embryonic cloning? |
BusinessWeek December 4, 2006 Moon Ihlwan |
Public Scorn For Private Equity Spurred by the outcry over huge profits, prosecutors are going after foreign firms. |
Reason July 2005 Ronald Bailey |
Censored Science Speaking out on stem cells: The Washington Post noted that even President Bush's handpicked NIH director, Elias Zerhouni, may not be on board with administration's stem cell policy. |
AskMen.com |
U.S. Journalists Pardoned North Korean leader Kim Jong Il has issued a "special pardon" to two American journalists convicted of sneaking into the country illegally, and he ordered them released during a visit by former U.S. President Bill Clinton, North Korean media reported early Wednesday. |
Chemistry World August 15, 2007 John Bonner |
Chemists Claim Biological Alchemy South Korean chemists say they have turned muscle cells from the sole of a human foot into something akin to stem cells, using a simple molecule called neurodazine. |
Salon.com August 21, 2000 Lori B. Andrews |
Embryos under the knife The latest reproductive technology is just the next step on our sprint toward human cloning. |
The Motley Fool July 26, 2004 Brian Gorman |
Stem Cell Researcher a Risk Geron could benefit from a new U.S. president, but in the end, studies of embryonic stem cells may or may not yield breakthroughs, so buying their stock now would be a gamble. |
Bio-IT World July 15, 2003 Kevin Davies |
Stem Cell Suicide The International Society for Stem Cell Research must engage in a political discourse to salvage the hope of embryonic stem cell research. |
Wired January 2003 Charles C. Mann |
The First Cloning Superpower Inside China's race to become the clone capital of the world. |
The Motley Fool February 2, 2005 Rich Duprey |
Aastrom to Leap Into Trials The biotech firm advances to the next stage of clinical studies in stem cell research. Investors, take note. |
Bio-IT World Dec 2005/Jan 2006 Maureen McDonough |
The Century of the Cell Like most new life science industries, the stem cell business landscape looks like a maze. There are many paths, turns, and dead-ends, but it is quite possible that there will be more than one route to the finish line. |
The Motley Fool September 29, 2010 Brian Orelli |
Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals. |
The Motley Fool August 27, 2007 Brian Orelli |
Repairing a Broken Heart Stem cells may be the new cure. If research continues on track, Geron expects to ask FDA to start clinical trials late next year or in early 2009. Investors, take note. |
Reason February 2005 Ronald Bailey |
The U.N. vs. Cloning In September 2004 President Bush strongly endorsed a United Nations resolution, proposed by Costa Rica, for a global treaty that would completely ban both reproductive cloning (that is, cloning to produce a baby) and therapeutic cloning. |
The Motley Fool November 9, 2004 Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
Inc. February 2005 Patrick J. Sauer |
The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan. |
Scientific American September 19, 2005 Charles Q. Choi |
Chatting Up Cells Stem cells can transform into whatever cell the body tells them to. Unfortunately, scientists have yet to master that particular gift of gab. But investigators may soon crack the language with tiny "chat rooms" for stem cells. |
Popular Mechanics November 27, 2007 Alex Hutchinson |
Stem Cells 2.0: Beyond the Hype, Engineers Look to Build Fast Engineers play the important role of making lab bench discoveries reproducible and efficient for use in industry. |
The Motley Fool December 1, 2008 Brian Orelli |
Obama Can't Save Stem Cell Companies While government-sponsored research on embryonic stem cells might eventually help scientists better understand all stem cells, it's not likely to help the companies right now. |
Wired June 2005 Clive Thompson |
How to Farm Stem Cells Without Losing Your Soul A solution to the stem cell dilemma that even the Vatican can love. |
The Motley Fool June 21, 2005 Brian Gorman |
Stem Cell Chatter Despite the promise suggested by early studies, embryonic stem cell research remains highly speculative. More concrete results, not the amount of cash being poured into research, are the best basis for investing decisions. |
The Motley Fool August 31, 2007 Brian Orelli |
A Stem-Cell Primer Public funding from states could help companies doing stem cell research. Read about Geron, StemCells, Osiris Therapeutics, ViaCell and Invitrogen, companies that may profit from the increased public spending. |
The Motley Fool December 22, 2009 Brian Orelli |
Pfizer Swings for the Fences A long shot, but at least it's cheap. Pfizer seems to have taken a particular liking to stem cells, having established a unit to study them last year |
Chemistry World April 6, 2009 Rebecca Trager |
US funding boost - a threat to EU science? These developments have raised some concern about the possibility of a 'brain drain' from Europe to the US, as these falling barriers have quickly made the region a more appealing destination for researchers. |
HHMI Bulletin Aug 2010 Lawrence Goldstein |
Hear from the author of "Stem Cells for Dummies" The author, an investigator at the University of California, San Diego, is reaching out beyond policymakers in an unorthodox way. He's co-written Stem Cells for Dummies. |
Salon.com January 9, 2003 Katharine Mieszkowski |
Fun with pig clones Every porker is different, even if it shares the same genes with a litter of siblings. So forget about ordering a copy of your favorite faithful companion. |
Chemistry World December 8, 2015 Liisa Niitsoo |
A sound idea for treating lung disease Scientists in Australia have made a portable device that gently vibrates stem cells with sound waves to turn them into an aerosol. The system could be an effective route for treating various pulmonary diseases. |
Wired January 2001 Brian Alexander |
(You)2 Human cloning has always been frightening, seductive - and completely out of reach. Not anymore... |
Salon.com December 29, 2000 Arthur Allen |
Will Thompson, Bush clash over human embryo research? The HHS nominee supports it, but right-to-lifers want it stopped.... |
Pharmaceutical Executive October 1, 2012 Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
BusinessWeek June 13, 2005 Arlene Weintraub |
A Boost for Broken Hearts? The Institute of Regenerative Medicine in Barbados is convinced that stem cells from fetuses can repair cardiac damage. |
Chemistry World February 4, 2011 Harriet Brewerton |
Transplant tracking Magnetic nanoparticles could be used to track neural stem cells after a transplant in order to monitor how the cells heal spinal injuries, say UK scientists. |
Scientific American January 17, 2007 Charles Q. Choi |
A Stroke for Stem Cells The brain becomes a target in stem cell clinical trials. |
Salon.com August 8, 2001 |
To clone or not to clone? As two scientists threaten to begin human cloning "within weeks," scientists and ethicists say the two are acting irresponsibly... |
The Motley Fool November 30, 2004 Rich Smith |
Breaking Rules and Saving Lives Cord blood offers an ethical means of using stem cells to heal illness. While two top companies in the field are private, over the counter traded Cryo-Cell lost as much money as it collected in revenues last year. |